openPR Logo
Press release

Aquigen Bio Launches Justicidin Impurity Standards Category to Advance Analytical Excellence in Phytochemical Drug Research

08-06-2025 09:45 AM CET | Chemicals & Materials

Press release from: Aquigen Bio Sciences

Aquigen Bio Launches Justicidin Impurity Standards Category

Aquigen Bio, a leading global provider of pharmaceutical reference materials and impurity standards, proudly announces the launch of its Justicidin Impurity Standards category-strengthening its commitment to support analytical precision and regulatory compliance in plant-derived compound analysis, especially in oncology, antimicrobial, and ethnopharmacological research.
The newly introduced product line includes:

Justicidin G
https://aquigenbio.com/product/justicidin-g/

Justicidin A
https://aquigenbio.com/product/justicidin-a/

Justicidin H
https://aquigenbio.com/product/justicidin-h/

Justicidin E
https://aquigenbio.com/product/justicidin-e/

These impurity standards are now available under the newly launched Justicidin category:
https://aquigenbio.com/products/impurity-standards/justicidin/

Why It Matters:
Justicidins are a group of naturally occurring lignans with growing relevance in oncology, anti-inflammatory, and antimicrobial drug development. As research into plant-based APIs intensifies, the need for robust impurity profiling and regulatory documentation becomes critical.

Aquigen Bio's Justicidin impurity standards are synthesized and characterized to support:
High analytical accuracy for method development and validation

Seamless global regulatory submissions aligned with phytopharmaceutical regulations

Enhanced impurity profiling for extract standardization and formulation integrity

Empowering Precision in Plant-Based Drug Development
With global regulatory expectations evolving for herbal and natural APIs, manufacturers, CROs, and R&D labs are under growing pressure to detect, quantify, and control trace impurities-including degradation products and structural analogs.

Aquigen Bio's new Justicidin impurity range is developed with a focus on:
Analytical Integrity
Each product undergoes rigorous QC using NMR, LC-MS, and HPLC, ensuring reproducible accuracy.

Global Regulatory Fit
Standards are prepared in alignment with applicable ICH, EMA, and AYUSH guidelines, making them suitable for submissions worldwide.

Custom Documentation
Every compound is supplied with detailed CoA, Mass Spectra, Chromatograms, and validation reports for full traceability and confidence in audits or filings.

Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Visit: www.aquigenbio.com

Aquigen Bio is a leading provider of certified reference standards, impurity profiling compounds, and research chemicals to pharma, biotech, and academic institutions worldwide. With a dedication to excellence and a focus on regulatory readiness, Aquigen empowers scientists to innovate with confidence.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Aquigen Bio Launches Justicidin Impurity Standards Category to Advance Analytical Excellence in Phytochemical Drug Research here

News-ID: 4134387 • Views:

More Releases from Aquigen Bio Sciences

Elevate Pharmaceutical R&D with Aquigen BioSciences' Precision‐Grade Flibanserin Impurity B: Custom Synthesis, Unmatched Purity, ANDA‐Ready Reference Standard to Drive Analytical Method Development and Regulatory Compliance
Elevate Pharmaceutical R&D with Aquigen BioSciences' Precision‐Grade Flibanser …
Flibanserin Impurity B is a reference standard used in pharmaceutical research and development. It is primarily applied during the analysis and validation of drug substances to identify, quantify, and control impurities that may be present in the final product. This impurity is associated with the parent compound, Flibanserin, a medication approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. Aquigen BioSciences offers Flibanserin Impurity B as a
Estradiol Valerate EP Impurity A - Premium Reference Standard for Analytical Development, Quality Control, and Regulatory Compliance in Pharmaceutical Research
Estradiol Valerate EP Impurity A - Premium Reference Standard for Analytical Dev …
Estradiol Valerate EP Impurity A is a high-quality reference standard designed to meet the stringent requirements of pharmaceutical research, method validation, and quality control processes. Explore Estradiol Valerate EP Impurity A : https://aquigenbio.com/product/estradiol-valerate-ep-impurity-a/ Manufactured and characterized with precision, this impurity standard supports laboratories and manufacturers in achieving consistent, reliable, and reproducible results in critical analytical workflows. With its exceptional purity and accurate characterization, Estradiol Valerate EP Impurity A plays a vital role
High-Purity N-Nitroso Betahistine D3 for Precise Pharmaceutical Analysis | Deuterated Nitrosamine Impurity Standard for Method Development, Validation, Quality Control, and Regulatory Submissions in Betahistine Impurity Profiling and Research
High-Purity N-Nitroso Betahistine D3 for Precise Pharmaceutical Analysis | Deute …
Product Overview N-Nitroso Betahistine D3 is a premium deuterated nitrosamine impurity standard, specifically developed for precise analytical testing in pharmaceutical laboratories. This reference standard is widely used for analytical method development, validation, and quality control processes to meet stringent regulatory guidelines. With exceptional purity, complete documentation, and reliable traceability, it is ideal for research, development, and compliance applications. https://aquigenbio.com/product/n-nitroso-betahistine-d3/ Key Features and Benefits Deuterated Design for Precision: The incorporation of deuterium improves mass spectrometric
Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impurity Standards
Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impur …
Aquigen Bio, a trusted supplier of pharmaceutical reference standards, today announced the expansion of its Icatibant Impurity Standards portfolio, designed to support drug developers, analytical laboratories, and research organizations with reliable materials for impurity profiling and quality control. Icatibant, a selective bradykinin B2 receptor antagonist, is widely used in the treatment of hereditary angioedema (HAE). Given its peptide-based structure, Icatibant is prone to the formation of impurities during synthesis and storage.

All 5 Releases